GlassScriptPhysician profile
Natalia Fullerton
NPI 1154689453
$2,748.61
in general payments reported to CMS, 2019-2025
15 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2021: $126 · 2022: $285 · 2023: $564 · 2024: $233 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $1,215.00 | 2019 | |
| Axogen | $403.31 | 2021-2025 | Avance Nerve Graft |
| Kerecis Limited | $179.15 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Innovation Technologies INC | $150.58 | 2023 | Irrisept |
| Allergan, INC. | $149.96 | 2022 | |
| Medartis INC. | $121.94 | 2024 | Aptus |
| Acera Surgical, INC. | $120.86 | 2022 | |
| Integra Lifesciences Corporation | $116.98 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $93.84 | 2019 | |
| Stryker Corporation | $54.79 | 2019 | |
| Organogenesis INC. | $41.82 | 2023 | Puraply |
| Polynovo North America LLC | $40.19 | 2024 | Novosorb Btm |
| Baxter Healthcare | $24.84 | 2019 | |
| Biotissue Holdings INC. | $21.10 | 2024 | |
| Sanara Medtech INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalia Fullerton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.